During the past decade, Sanatorio CEMSI Chapultepec (For Emergencies Only) conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sanatorio CEMSI Chapultepec (For Emergencies Only)" are "Psoriatic Arthritis" (2 trials). Many other conditions were trialed in "Sanatorio CEMSI Chapultepec (For Emergencies Only)" in a lesser frequency.

Most popular intervention types in "Sanatorio CEMSI Chapultepec (For Emergencies Only)" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Adalimumab" (1 trials), "Tofacitinib" (1 trials), "Tofacitinib 10 mg BID" (1 trials) and "Tofacitinib 5 mg BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanatorio CEMSI Chapultepec (For Emergencies Only)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sanatorio CEMSI Chapultepec (For Emergencies Only)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sanatorio CEMSI Chapultepec (For Emergencies Only), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sanatorio CEMSI Chapultepec (For Emergencies Only), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".